AI
MDSO

Axiom Investors’s Medidata Solutions, Inc. MDSO Stock Holding History

Axiom Investors’s Portfolio MDSO Stock Details MDSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,634
Closed -$1.52M – 132
2019
Q3 		$1.52M Sell
16,634
-6,536
-28% -$597K 0.04% 103
2019
Q2 		$2.1M Buy
23,170
+5,825
+34% +$511K 0.06% 98
2019
Q1 		$1.27M Sell
17,345
-37,387
-68% -$2.7M 0.04% 114
2018
Q4 		$3.69M Sell
54,732
-4,045
-7% -$285K 0.13% 85
2018
Q3 		$4.31M Sell
58,777
-18,458
-24% -$1.48M 0.12% 89
2018
Q2 		$6.22M Buy
77,235
+32,683
+73% +$2.45M 0.19% 70
2018
Q1 		$2.8M Sell
44,552
-10,502
-19% -$699K 0.07% 113
2017
Q4 		$3.49M Sell
55,054
-44,452
-45% -$3.17M 0.09% 104
2017
Q3 		$7.77M Buy
99,506
+13,886
+16% +$1.06M 0.17% 80
2017
Q2 		$6.7M Buy
85,620
+29,400
+52% +$2.05M 0.16% 79
2017
Q1 		$3.24M Buy
56,220
+21,134
+60% +$1.14M 0.08% 98
2016
Q4 		$1.74M Buy
35,086
+10,648
+44% +$553K 0.05% 133
2016
Q3 		$1.36M Buy
+24,438
New +$1.29M 0.04% 102

Other funds holding MDSO

WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

Axiom Investors's MDSO Position: Q4 2019 in Review

Axiom Investors sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 16,634 shares — an estimated $1.52M sold.

Axiom Investors first reported a position in MDSO in Q3 2016 and held it in 13 quarters. The position peaked at $7.77M in Q3 2017. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

  • Axiom Investors reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
  • Axiom Investors sold 16,634 Medidata Solutions, Inc. shares in Q4 2019, an estimated $1.52M.
  • Axiom Investors first reported a position in Medidata Solutions, Inc. in Q3 2016 and held it in 13 quarters.
  • Axiom Investors's Medidata Solutions, Inc. position peaked at $7.77M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on Axiom Investors's 13F filing for Q4 2019, filed 13 Feb 2020.